We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.56B
AUM Growth
-$38.5M
Cap. Flow
-$387M
Cap. Flow %
-24.76%
Top 10 Hldgs %
13.79%
Holding
357
New
58
Increased
94
Reduced
104
Closed
53

Top Buys

Rank Stock Value
1
AGN.PRA
Allergan plc
AGN.PRA
+$15.9M
2
AVGO icon
Broadcom
AVGO
+$7.71M
3
FCAM
Fiat Chrysler Automobiles N.V.
FCAM
+$7.55M
4
VC icon
Visteon
VC
+$6.62M
5
MGM icon
MGM Resorts International
MGM
+$6.53M

Top Sells

Rank Stock Value
1
ACT.PRA
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
+$13.6M
2
VEEV icon
Veeva Systems
VEEV
+$9.49M
3
ALL icon
Allstate
ALL
+$9.41M
4
PAY
Verifone Systems Inc
PAY
+$8.26M
5
URI icon
United Rentals
URI
+$6.43M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.11%
2 Healthcare 12.19%
3 Technology 11.28%
4 Financials 9.06%
5 Industrials 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCOY
251
Decoy Therapeutics
DCOY
$2.16M
– –
0
– –
PBPB
252
DELISTED
Potbelly
PBPB
$752K 0.05%
+61,423
New +$862K
NFLX icon
253
Netflix
NFLX
$307B
$739K 0.05%
551,040
-91,840
-14% -$769K
AL
254
DELISTED
Air Lease Corp
AL
$729K 0.05%
21,500
+9,972
+87% +$377K
BIIB icon
255
Biogen
BIIB
$30.5B
$341K 0.02%
+845
New +$339K
TCON
256
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$340K 0.02%
150
– –
APPF icon
257
AppFolio
APPF
$6.87B
$323K 0.02%
+22,891
New +$320K
ALDX icon
258
Aldeyra Therapeutics
ALDX
$95.9M
$317K 0.02%
40,788
+32,455
+389% +$280K
ITCI
259
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$260K 0.02%
+8,130
New +$206K
ALPN
260
DELISTED
Alpine Immune Sciences Inc
ALPN
$192K 0.01%
+3,167
New +$189K
TRIL
261
DELISTED
Trillium Therapeutics Inc.
TRIL
$159K 0.01%
+7,304
New +$167K
AAL icon
262
American Airlines Group
AAL
$10.6B
– –
-86,430
Closed -$4.56M
ADVM
263
DELISTED
Adverum Biotechnologies
ADVM
– –
-3,289
Closed -$371K
ALL icon
264
Allstate
ALL
$69.6B
– –
-132,228
Closed -$9.41M
ANET icon
265
Arista Networks
ANET
$243B
– –
-1,176,608
Closed -$5.19M
BOOT icon
266
Boot Barn
BOOT
$4.97B
– –
-156,956
Closed -$3.75M
CMG icon
267
Chipotle Mexican Grill
CMG
$42.7B
– –
-383,300
Closed -$4.99M
CNK icon
268
Cinemark Holdings
CNK
$4.4B
– –
-124,146
Closed -$5.59M
CRM icon
269
Salesforce
CRM
$153B
– –
-13,706
Closed -$916K
CSGP icon
270
CoStar Group
CSGP
$12B
– –
-34,220
Closed -$677K
F icon
271
Ford
F
$55B
– –
-101,591
Closed -$1.64M
FRPT icon
272
Freshpet
FRPT
$3.21B
– –
-120,893
Closed -$2.35M
GIII icon
273
G-III Apparel Group
GIII
$1.51B
– –
-109,822
Closed -$3.09M
GOOG icon
274
Alphabet (Google) Class C
GOOG
$4.36T
– –
-90,127
Closed -$2.49M
GPRO icon
275
GoPro
GPRO
$126M
– –
-84,128
Closed -$3.65M
9 10
11
12 13

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Nicholas Investment Partners held 357 positions worth $1.56B, down 2.4% from $1.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Nicholas Investment Partners withdrew a net $387M in Q2 2015, closing 53 positions and reducing 104 holdings. Its most notable exit was ACTAVIS PLC Pfd Conv Ser A (Irl), an estimated $13.6M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Nicholas Investment Partners opened a new position in Allergan plc worth $15.9M.

  • Nicholas Investment Partners's largest Q2 2015 buy was Allergan plc: 15,220 shares worth $15.9M.
  • Nicholas Investment Partners added most to Visteon in Q2 2015, an estimated $6.62M increase.
  • Nicholas Investment Partners's biggest Q2 2015 reduction was Illumina, cutting an estimated $6.06M.
  • Nicholas Investment Partners fully exited ACTAVIS PLC Pfd Conv Ser A (Irl) in Q2 2015, selling an estimated $13.6M.
  • Nicholas Investment Partners's ten largest holdings make up 14% of its $1.56B portfolio in Q2 2015.
  • Nicholas Investment Partners opened 58 new positions and closed 53 in Q2 2015.
  • Nicholas Investment Partners's portfolio value fell 2.4% quarter-over-quarter to $1.56B.

Based on Nicholas Investment Partners's 13F filing for Q2 2015, filed 17 Aug 2015.